Power Prices Plummet as State Nears 100% Renewable Energy Transition

Discover the Massive Solar Power Plant of Port Augusta, South Australia

Brooke Mitchell/Getty Images

As South Australia progresses toward achieving its ambitious goal of operating entirely on solar and wind energy, electricity prices have decreased by one-third over the past year, making them the lowest in Australia. This state serves as a leading example of the economic advantages linked to large-scale grid decarbonization.

Tim Buckley, an independent energy analyst at Climate Energy Finance, an Australian think tank, highlights that South Australia has emerged as a global leader in renewable energy transition. While this transformation comes with challenges, we take pride in our successes. South Australian consumers are now reaping the benefits of consistently low electricity prices,” he states.

In the final quarter of 2025, South Australia generated an impressive 84% of its electricity from solar and wind sources. This exceptional percentage makes it the highest among major global power grids, with plans to reach 100% by the end of next year.

This renewable energy push is driving electricity prices down. The Independent Australian Energy Market Operator (AEMO) reported that South Australia’s average wholesale electricity price fell by 30% in the last quarter of 2025 compared to the previous year. Consequently, the state now shares the title of Australia’s cheapest state with Victoria, which also boasts a significant share of renewable energy.

This is a significant achievement for the South Australian government, previously criticized for rising electricity prices due to rapid renewable energy implementation. Occasionally, electricity bills surged as the state relied on costly gas energy when wind and solar outputs dwindled. Gas producers charged high prices to meet sporadic demand, a challenge exacerbated by rising petrol prices in Australia, which surged by 500% following Russia’s invasion of Ukraine.

To reduce price fluctuations, South Australia has developed seven extensive batteries comparable to football fields. These batteries harness energy generated by nearby solar and wind farms on sunny, windy days, providing backup power when conventional sources fall short. The introduction of two new batteries in 2025 significantly contributed to lowering energy costs.

The success of these batteries has motivated other Australian states to invest in similar technologies. Last week, consultancy Rystad Energy noted in a report that utility-scale batteries are no longer merely supplementary technology in Australia’s energy landscape, actively replacing gas fueled generation across several states. Consequently, Australia is becoming a global showcase for the effectiveness of battery technology in energy storage.

A new massive wind farm in South Australia, named Goyder South, which opened in October, is also contributing to lower electricity prices. With a capacity of 412 megawatts, it is the largest in the state and is expected to boost wind energy generation by 20%. Buckley emphasizes, “Basic economics indicates that increasing supply leads to reduced prices.”

AEMO’s report also highlighted that wholesale electricity prices were negative for approximately 48% of the time in the past quarter, indicating that the state produced more electricity than consumed, resulting in incentives for electricity suppliers to halt production during excess generation periods.

For instance, in November, South Australia achieved a remarkable milestone when it met 157% of its electricity demand solely through renewable energy. In these instances, excess wind and solar power caused temporary disconnections from the grid, allowing batteries to store the surplus energy for later use or export to nearby Victoria.

Many households in South Australia are also reducing their dependency on grid electricity by generating their own power. Over half of the residences now have solar panels installed, harnessing daytime sunlight for energy. Additionally, nearly 50,000 households have invested in home storage batteries, charged during the day and utilized after sunset. Since the launch of a 30% rebate on household batteries in July 2025, South Australia leads the nation in per capita home battery installations.

In December, the state concluded agreements to construct two additional large-scale wind farms, vital steps toward achieving its goal of 100% net renewable energy by next year. “We are well on our way to achieving this target, and the new wind farms will play a critical role in this success,” Buckley stated.

Fossil Hunting in the Australian Outback

Embark on an extraordinary adventure through the fossil-rich landscapes of eastern Australia, a region that was once a shallow inland sea millions of years ago. Join us for 13 unforgettable days as we delve deep into the hinterland, follow the ancient trails of colossal prehistoric creatures, and explore the incredible secrets of Earth’s ancient past.

Topics:

Source: www.newscientist.com

Projected Decline in Weight Loss Drug Prices by 2026: What You Need to Know

Massive demand for weight loss medications

Surge in demand for drugs like Wegovy, Victoza, and Ozempic leads to shortages

Michael Silk/Alamy

The blockbuster weight loss drug semaglutide, along with competitors, offers potential solutions to the global obesity crisis. However, access remains limited for many who could greatly benefit from these innovations, though changes are on the horizon.

Historically, weight loss drugs have been scarce; yet, by the end of 2024, manufacturers are expected to meet the skyrocketing demand. Nevertheless, treatments like semaglutide (marketed as Wegovy or Ozempic) continue to carry hefty price tags, often reaching thousands of dollars annually.

This pricing structures keeps these essential medications out of reach for the over 1 billion individuals affected by obesity globally. In the U.S., a mere 3 percent of the population utilizes weight-loss medications, with the numbers dipping below 1 percent in other countries, according to Morgan Stanley.

Looking ahead, 2026 promises significant developments, including the approval of orforglipron in multiple countries. This new medication mimics the GLP-1 hormone, known for its appetite-reducing properties. Unlike semaglutide, orforglipron, as a small molecule, offers tablet-based administration.

“Tablets are inexpensive to produce, simple to store, and easy to distribute,” explains Dr. Laura Heisler from the University of Aberdeen, UK. “In essence, the medication can reach a broader audience in need.”

In contrast, semaglutide is a larger molecule and a type of protein. Polymer drugs like these are generally challenging and costly to produce. They often require injections, complicating their supply and driving up costs. This has been a significant barrier to fulfilling the demand for GLP-1 drugs.

It’s important to note that there is a semaglutide version in pill form, Rybelsus, approved for type 2 diabetes. Novo Nordisk, the manufacturer, has also sought approval for a weight loss variant.

However, Rybelsus isn’t just any medication; it includes semaglutide alongside sulcaprosate sodium, which neutralizes stomach acid to facilitate absorption into the bloodstream. To maximize effectiveness, it must be taken at least 8 hours post-meal, with no food or drink for 30 minutes.

This complexity is part of the reason orforglipron has a lower production cost compared to semaglutide—it can be taken without the stringent requirements of medications like Rybelsus.

Furthermore, the introduction of orforglipron will foster competition among pharmaceutical companies. While Lilly, the producer of Orforglipron, has yet to disclose pricing, it has been shown to be less costly than other GLP-1 alternatives.

The sole drawback is that orforglipron appears less effective; those on the highest doses typically lose about 10% of body weight over 72 weeks, compared to 14% with semaglutide. Further research is needed to validate these findings.

Another critical development is the anticipated expiration of semaglutide patents in nations such as China, India, Brazil, Canada, and Turkey—home to a significant population. This could pave the way for generic versions to enter the market.

Although generics must meet the same standards as their branded counterparts, they often come at a fraction of the cost. “Once a drug loses patent protection, generic competition usually leads to price reductions of up to 90%,” states Jeremy Durant of Medicines UK, the association for generic drug manufacturers.

This shift may expand access to these crucial treatments. That said, the World Health Organization (WHO) recently advised that patients should also receive counseling about behavioral modifications and lifestyle changes to maximize the efficacy of medications. “Drugs alone won’t address the global obesity crisis,” says Francesca Ceretti of WHO.

Topics:

Source: www.newscientist.com

Are Slate Auto Electric Trucks the Solution to High Car Prices?

Social media buzzed with reactions when startup Slate Auto unveiled its electric pickup truck priced at approximately $25,000 last month. The vehicle’s simplistic design features a silent body and nostalgic hand crank windows.

How wild is it? According to Cox Automotive, average monthly payments for new vehicles surged to $739 in March, up from $537 in January 2019. The average cost of a new car is now $47,400, while electric models are around $59,200. The high interest rate, currently about 9.4% on a 72-month loan, has further strained finances for buyers.

“Prices and interest rates are exceptionally high,” stated Mark Schirmer, director of industry insights at Cox Automotive. “For consumers who haven’t been in the market since 2018, the cost of a vehicle might seem shocking.”

President Trump’s 25% tariffs on imported automobiles and parts have prompted consumers to buy now, fearing further price increases. Cars priced below $30,000 are particularly vulnerable, with nearly 80% facing these tariffs. This includes popular models like the American-made Honda Civic and Toyota Corolla. The supply of budget-friendly models is expected to dwindle as automakers may cease the importation of certain vehicles entirely.

Enter Slate, a suburban Detroit startup backed by venture capital and Amazon founder Jeff Bezos.

Former Fiat executive Chris Berman, now CEO of Slate, mentioned that their trucks won’t be available until late 2026 but are intentionally designed to alleviate sticker shock.

True to its name, the truck serves as a blank canvas, enabling buyers to customize with over 100 accessories, such as power windows and heated seats, as their budgets allow or needs evolve. While it lacks built-in stereo or touchscreen display, it features a dock for phones and tablets, which saves costs and helps avoid the digital obsolescence often seen in car entertainment systems.

“I believe hardworking Americans are seeking value for their money,” Berman expressed in a recent interview.

This message resonated with 41-year-old Liv Leigh, who secured a slate truck reservation during its public debut at Long Beach Airport in California last April, paying $50 to do so.

She observed Slate employees convert the two-seat pickup into a five-seater SUV in just about an hour. Lee values the compact size of the truck, which is smaller than a Civic, along with its moderate 150-mile range.

“I love the concept of a utilitarian truck, a basic model that can handle dogs, muddy bikes, and plywood easily,” Lee remarked. “We don’t need a massive vehicle for our needs.”

Berman emphasized that efficient design and manufacturing are critical to maintaining the low price of their trucks. The grey plastic composite body panels eliminate the necessity for costly steel body stamping facilities or paint shops.

Just as the Ford Model T was available only in black, the Slate grants buyers a choice of 13 colors of vinyl body wraps for an additional $500. Customers can also opt for larger factory-installed batteries that extend the range to 240 miles.

“This approach keeps costs down while offering customers the freedom of choice,” said Berman. “They can customize their vehicles as per their preferences rather than adhering to manufacturer standards.”

Slate anticipates that its US-based supply chain, including batteries produced by South Korea’s SK On, will qualify for a $7,500 federal tax credit. However, some Republican lawmakers recently introduced a budget bill that removes this incentive and dismantles other Biden-era climate and energy policies.

Success hinges on Slate’s ability to navigate the treacherous landscape of electric vehicle startups, as several young manufacturers like Fisker, Nikola, and Canoo have sought bankruptcy protection.

Regardless of subsidies, Berman remains optimistic about Slate’s business strategy.

The company aims to price the truck around $20,000 before any government incentives, hoping to become a contender against the Nissan Leaf, which is the most affordable electric vehicle at $29,300 but no longer qualifies for tax credits. Chevrolet is set to release a redesigned Bolt SUV for roughly $30,000 by year-end, which will qualify for a tax credit, reducing its effective price to about $22,500.

Erin Keating, executive analyst at Cox Automotive, has praised the slate truck’s originality. However, she noted that the two-seat pickup’s short range and minimalistic interiors might not attract American buyers accustomed to high-tech features and comforts.

“There’s no harm in attempting to resolve the affordability crisis, but I question whether this will become a high-volume seller,” Keating commented. “Ultimately, this is a compact EV that offers very little. It doesn’t improve the array of affordable options with longer ranges.”

The Ford Maverick poses a potential challenge to the Slate, as its compact pickup is two feet longer, seating five passengers and featuring even more amenities. The hybrid version achieves 40 miles per gallon, with over 500 miles of range on a full tank.

Ford sold 131,000 Mavericks last year, indicating substantial demand for small, fuel-efficient trucks. The company has raised the starting price for hybrid versions to $28,150 as of 2024 due to tariffs on trucks assembled in Mexico. Ford confirmed that it would not pass on the entire tariff burden to consumers, offering vehicles at a price equivalent to employee sales until early July.

As with all vehicle types, American pickups have morphed dramatically over the years, with some extravagant models costing as much as luxury European sedans. Electric trucks from Tesla, Rivian, and Ford range from $70,000 to $100,000 or even higher.

Berman is keeping an eye on market opportunities for personas such as entry-level truck enthusiasts, families seeking a second vehicle, empty-nesters, landscapers, contractors, and delivery personnel. The company anticipates selling more trucks to customers who would typically opt for used cars, with an average price point estimated at $26,000.

A significant hurdle for Slate and other firms aiming to sell more affordable vehicles is that many Americans don’t appear to be purchasing such offerings, despite their stated preferences.

Keating highlighted that around 20 models currently available start below $25,000, predominantly small cars or SUVs, including the $18,300 Nissan Versa, the lowest-priced car on the market.

Almost all mid-sized family sedans start below $30,000, including popular models like the Honda Accord, Toyota Camry, and Hyundai Sonata. Yet, many Americans favor larger vehicles; SUVs, pickups, and minivans now comprise over 80% of the market.

Trump’s trade policies remain unpredictable. Analysts hope tariffs will add thousands to new car prices, subsequently increasing demand and prices for used vehicles.

In April alone, Americans purchased 1.5 million new cars, 400,000 more than in April 2024. However, analysts have noted that buyers are acting now to avoid being caught in a crunch later. Jonathan Smoke, chief economist at Cox Automotive, mentioned that new car inventories have reached their lowest point in two years, indicating potential price increases as dealerships sell out ahead of impending tariffs. Meanwhile, S&P Global Mobility has reduced its forecasts for new car sales, anticipating a 4% decline this year.

For those seeking refuge amidst financial uncertainty, electric vehicles present a sound investment, according to Keating. New electric vehicles received an average discount of 13.3% in March, translating to savings of nearly $8,000.

Lee recently leased a Chevrolet Equinox for two years, paying $5,500 upfront, resulting in a monthly payment of $230. The electric SUV boasts a 319-mile range. “Many people aren’t aware of the extensive incentives available,” she noted.

Source: www.nytimes.com

Trump’s Proposal Will Connect Certain Drug Prices to State Payments

Updated May 12th: Additional insights Executive Order and its implications .

On Monday, President Trump is set to sign an executive order aimed at reducing various drug prices in the US by aligning them with what other prosperous nations pay. This was reported by True Social on Sunday evening.

He noted that his proposal cannot alter federal policies, describing it as the “most favored nation” pricing approach. While specifics regarding the types of insurance covered or the number of drugs affected were not shared, Trump emphasized that the US must secure the lowest prices compared to its counterparts.

“In the end, our nation will be treated equitably and citizens’ healthcare expenses will decrease significantly,” he stated in a social media update.

This kind of plan is likely to face legal challenges, and it remains uncertain whether it will succeed without input from Congress.

During his first term, Trump attempted to implement a similar Medicare strategy, targeting 68 million Americans aged 65 and older or those with disabilities. This plan would have focused on 50 medications administered in healthcare settings funded by Medicare. However, it was blocked by a federal court, which ruled that the administration bypassed necessary procedures in policy formulation.

The pharmaceutical sector strongly opposes this concept, arguing it may severely impact their profit margins. They have ramped up lobbying efforts against the proposal as discussions revive in Washington. Industry leaders caution that such measures will hinder research funding and limit patient access to innovative treatments.

“Every form of government pricing is detrimental to patients in America,” declared Alex Schriver, a staff member of a prominent pharmaceutical lobbying organization. He added: “Policymakers should prioritize reforming flaws in the US system instead of adopting ineffective strategies from abroad.”

Trump’s support for these ideas distinguishes him from the majority of Republicans, who are generally hesitant about government pricing. Meanwhile, Democrats are advancing a similar proposal.

Amiet Salpatwali, a pharmaceutical policy specialist at Harvard Medical School, noted that Trump is capitalizing on ideas that resonate with populist sentiments.

Trump has long expressed concerns about the significant disparity in drug prices that the US faces compared to other wealthy nations. He is correct; in the United States, the cost of branded medications is, on average, three times higher than that in peer countries.

This is despite the fact that a substantial portion of the research leading to new drugs is conducted in American laboratories and hospitals.

Pharmaceutical manufacturers generate a significant majority of global profits from US sales, typically developing their strategies with the US market in mind.

The pharmaceutical industry contends that the elevated prices in the US provide additional advantages. Analyses funded by the industry have indicated that US patients tend to access medications more swiftly and face fewer insurance restrictions compared to their counterparts in other countries.

Source: www.nytimes.com

Trump Signs Executive Orders Urging Businesses to Reduce Drug Prices

On Monday, President Trump signed an executive order urging drug manufacturers to voluntarily reduce prices for major medications in the United States.

Nonetheless, the order lacks explicit legal authority to enforce lower prices. It states that if drug companies do not comply, the administration may explore regulatory actions from foreign nations or consider importing drugs from abroad.

This seemed like a win for the pharmaceutical sector, backing policies that could severely impact their profits.

Last week, Trump emphasized the announcement, stating it was “significant enough to make an impact.” He also mentioned in a Sunday evening post on Truth Social that they would connect U.S. drug prices to those in comparable countries under the “most favored nation” pricing model.

His executive order won’t achieve that goal. Following the news, drug stocks surged on Monday.

This order by Trump came just hours after House Republicans slashed about $700 billion from the Medicaid and Obamacare markets, proposing extensive healthcare changes that could potentially leave 8.6 million Americans without insurance. Congress declined to include measures that would impose direct limits on drug prices in its packages.

The executive order also called for federal agencies to investigate the reasons behind lower prices in European nations and to pursue additional payments. The Trump administration has limited power to influence drug prices in Europe.

“I’m not criticizing pharmaceutical companies,” Trump remarked before signing the order. “I’m primarily critiquing the country rather than the pharmaceutical firm.”

Trump opted not to suggest measures that could be more effective, such as proposing that the administration collaborate with Congress to reform how government health programs compensate for certain drugs.

“The executive order seems more like an ambitious statement than a genuine effort to initiate policy shifts,” commented Amith Salpatwali, a medical policy student at Harvard Medical School.

While numerous Republican lawmakers have resisted attempts to control drug prices, Trump has consistently challenged the existing system, pointing out that U.S. drug companies charge significantly more than their counterparts globally.

“We plan to support pharmaceutical companies in other countries,” he said at an event on Monday.

Trump also threatened to leverage trade policies to pressure European nations into paying higher prices for prescription drugs. However, pharmaceutical companies are already tied to government contracts, and attempts to raise prices for new drugs could be met with resistance from European countries. Experts warned that an increase in prices in Europe does not automatically result in lower prices in the U.S.

During his first term, Trump aimed to implement a more comprehensive policy to reduce drug prices for Medicare, a health insurance program for those over 65 or with disabilities. This plan would have impacted only 50 drugs administered in clinics and hospitals, but a federal court blocked it, determining that the administration sidestepped due process in policymaking.

If pursued correctly, it’s uncertain whether the policy could have survived legal scrutiny. Some experts opined that Trump required congressional support to enact the law.

The White House heralded the announcement as groundbreaking. Trump’s Monday executive order calls for broader reforms than were proposed during his first term, potentially affecting more drugs and all Americans instead of just some Medicare patients. However, there is no clear pathway for implementing price reductions.

“It almost seems like: we want a lower price and will see what happens,” remarked Stacey Dusetzina, a health policy professor at Vanderbilt University, who studies drug pricing. She added that in the absence of more substantive actions, “I don’t foresee drug prices decreasing anytime soon.”

The order stated that if initial measures do not yield notable progress in lowering U.S. drug prices, the Trump administration may “consider a regulatory plan to impose pricing standards based on the most favored nations.”

Democrats have introduced numerous bills aimed at aligning American drug prices with those in other countries, and laws passed during the Biden administration now allow Medicare to directly negotiate prices for a limited selection of drugs used in the program. Overall, drug pricing policies enjoy broad public support across both Republican and Democratic voters.

The pharmaceutical industry has voiced its concerns over potential tariffs on imported drugs that Trump has promised to impose immediately. These tariffs are likely to reduce drug manufacturers’ profits, even as they might increase some drug prices in the U.S. and pass on additional costs.

Investors reacted positively, recognizing that Trump did not propose more substantial policies. After earlier declines, drug stocks rebounded when details of Trump’s announcement emerged, with Merck shares rising 6% and Pfizer’s shares nearly 4%. The small biotech stock index also rose by 4%.

“Better than expected,” a Wall Street Bank analyst mentioned in a note to investors. “More bark than bite,” commented analysts at TD Cowen.

In Monday’s statement, a drugmaker lobbying group asserted that the U.S. should not look to other countries to determine drug pricing.

However, significant industry organizations, including PhRMA, commended Trump for using trade negotiations to pressure foreign governments to “pay their fair share for medicines.”

“U.S. patients should not bear the financial burden of global innovation,” stated Stephen J. UBL, PhRMA’s CEO.

Currently, U.S. brand drug prices are three times higher on average compared to similar countries.

Drug manufacturers typically design their business strategies around U.S. profits. Essentially, U.S. profits drive their revenues.

Pharmaceutical companies assert that U.S. prices accompany additional advantages. Industry-funded analyses show that U.S. patients gain faster access to medications, and experience fewer insurance limitations compared to other regions.

In many affluent countries, governments generally cover prescription drug costs for the entire population, negotiating substantial discounts with drug manufacturers. Numerous other nations employ comparative pricing to establish what they are willing to pay.

In contrast, the U.S. government has minimal direct involvement in setting drug prices, aside from the Biden-era program affecting a limited number of Medicare drugs, which is currently under the Trump administration’s oversight.

Earlier this month, Republican Senator Josh Hawley from Missouri and Democrat Peter Welch from Vermont introduced a bill aimed at capping the average prices paid based on peer country comparisons.

In an interview, Welch expressed agreement with Trump’s assertion that Americans are overpaying for drugs and believes that international comparisons could help establish fairer pricing. However, he emphasized that congressional action is necessary to create enduring policies.

“It’s essential to tackle this legislatively,” he stated.

Trump’s executive order assigns his administration a month to communicate voluntary “price targets” for select drugs to pharmaceutical companies. White House officials indicated that it is likely that a weight-loss drug known as GLP-1 (which includes popular medications like Zepbound and Wegovy) might be among those discussed.

Trump noted at a press conference on Monday that the costs for “weight-loss drugs” are substantially lower in Europe than in the U.S.

In many scenarios, Americans face costs of around $500 a month for these medications without insurance, while European pharmacies often charge a few hundred dollars less. Most patients in Europe pay out-of-pocket for drugs, as the national health systems typically do not cover them.

Source: www.nytimes.com

Trump’s Proposal Ties Certain Drug Prices to State Payments

On Monday, President Trump plans to sign an executive order intending to reduce various US drug prices by aligning them with the rates paid by other affluent nations. True Social reported on Sunday evening.

The proposal, referred to as the “most favored nation” pricing model, cannot alter federal policies. Trump did not specify which insurances or drugs would be included, but asserted that the US should secure the lowest price among comparable countries.

“Our nation will be treated fairly, and citizens’ healthcare costs will drop to unprecedented levels,” he stated in a social media update.

This initiative may face legal challenges, and it remains uncertain if it can proceed without legislative action.

During his first term, Trump attempted to implement a version of this Medicare concept. It would have affected 68 million Americans aged 65 and older or those with disabilities. The proposal would have targeted only 50 drugs given in clinics and hospitals reimbursed by Medicare, but a federal court blocked it, citing procedural oversights by the administration.

The pharmaceutical sector staunchly opposes this notion, fearing significant cuts to their profits. They have been actively lobbying against it as policy discussions have intensified in Washington in recent weeks. Companies caution that such measures could lead to reduced research funding and limit patient access to new medications.

“Government pricing in any form is detrimental to patients in America,” stated Alex Schriver, an employee of a prominent pharmaceutical lobbying group. He added, “Policymakers should concentrate on addressing flaws in the US system rather than adopting unsuccessful policies from abroad.”

Trump’s openness to these ideas distinguishes him from the majority of Republicans, who are generally skeptical of government pricing. Democrats are also proposing a version of the concept.

Amiet Salpatwali, a pharmaceutical policy expert at Harvard Medical School, noted that Trump is capitalizing on ideas that carry “populist appeal.”

Trump has long complained that the US pays much higher prices for the same drugs compared to other affluent countries. His claim holds merit: in the US, branded drug prices are on average three times higher than those in peer nations.

This disparity occurs even though a significant portion of the research that leads to new drugs is performed in American laboratories and hospitals.

Pharmaceutical firms generate a considerable majority of their global profits from US sales, often tailoring business strategies to the US market.

The industry asserts that higher prices in the US have certain advantages. According to industry-funded analyses, patients in the US access medications more rapidly and face fewer insurance restrictions compared to other nations.

Source: www.nytimes.com

Microsoft to Increase Xbox Prices Globally Due to Tariff Uncertainties

On Thursday, Microsoft revealed plans to increase Xbox console prices globally, referencing “market conditions,” just days after Sony implemented a similar change for the PlayStation 5.

The tech giant will also elevate the prices of various new games produced by its video game subsidiaries.

In the US, the base model, Xbox Series S, will rise from $299.99 to $379.99, marking a 27% increase. The Premium Series X Galaxy Black model will now be available for $729.99, up 22% from the prior price of $599.99. Furthermore, selected new games from Microsoft-owned studios will cost $79.99, reflecting a 14% hike from the current $69.99.

In Europe, the Series S price has shifted from 299.99 euros to 349.99 euros, an increase of 17%. In Australia, the Series S starts at $549, while the Series X begins at $849.

“We recognize that these adjustments will be challenging and have been made after careful consideration of market conditions and escalating development expenditures,” the company stated on its website.

Skip past newsletter promotions

Though Microsoft hasn’t explicitly cited it, Donald Trump’s tariffs on various trading partners have loomed over the gaming sector.

Xbox consoles, primarily manufactured in China, face US tariffs as high as 145% on numerous products enacted during the Trump administration.

The Series S and X models launched in late 2020 and have sold around 30 million units, according to industry analysts.

In mid-April, Sony announced price hikes for several PlayStation 5 models in select markets, including Europe, while notably excluding the US. Like Xbox, the PS5 is predominantly assembled in China. Additionally, Nintendo has similarly postponed pre-orders for the Switch 2 console, which debuted shortly before Trump’s tariff announcement.

Source: www.theguardian.com

Amazon’s Mixed Revenue Report Causes Stock Prices to Decline

While Amazon aimed to highlight President Trump’s trade war, it was an unavoidable challenge for the leading online retailer in the U.S.

Initially, the e-commerce giant found itself amid a brief controversy on Tuesday, intertwined with misleading reports suggesting that Amazon revealed customs costs to shoppers.

Just two days later, economic realities hit when Amazon announced its slowest growth in North American retail history.

The company’s largest region contributed to first-quarter financial results, reflecting sluggish sales growth since the peak of the pandemic. Sales from January to March climbed to $155.7 billion, representing a 9% increase from the same period last year. Profits surged 64% to reach $17.1 billion.

For the quarter ending in June, Amazon has advised investors to anticipate revenues between $159 billion and $164 billion, with operating profits expected to decline to $13 billion. The company has included “tariffs and trade policies” as factors contributing to uncertainty in their forecasts.

The results were mixed in comparison to Wall Street expectations, leading to a more than 3% decline in Amazon’s stock during after-hours trading following the earnings release.

“None of us can predict precisely where the tariffs will land or when they will take effect,” stated Amazon CEO Andy Jassy during an investor call. He emphasized the company’s strong focus on reducing prices by procuring additional stock before tariffs are implemented, aiding sellers on Amazon’s platform to do the same.

Investors are analyzing how unforeseen tariffs, not addressed by President Trump, will impact Amazon’s customers. Some speculate that consumer purchases might have accelerated in March and April to avoid impending tariffs, leading to increased spending in otherwise unstable conditions.

Jassy noted that Amazon customers had made “advanced purchases” of certain product types but did not specify which ones.

Various elements contribute to Amazon’s retail revenue. Online product sales directly to consumers increased by 5% to $57.4 billion, while services provided to sellers on the platform grew by 6% to $36.5 billion.

Advertising, viewed by investors as a burgeoning and lucrative sector, rose 18% to $13.9 billion.

Investors have consistently focused on Amazon’s cloud computing division, which generates the majority of the company’s profits. Jassy, who previously led the cloud business before becoming CEO, is expanding the company’s artificial intelligence capabilities. The cloud sector grew by 17% in the first quarter, totaling $29.3 billion.

Jassy remarked that if Amazon had more capacity in its data centers, it could have offered even more cloud services. He mentioned the construction of a new facility equipped with advanced internet and AI-powered technology to alleviate constraints in the coming months. The company is striving to enhance its infrastructure, having reported more than $24 billion in spending during the first three months of the year, which is about $2 billion less than the previous quarter. In February, Amazon announced plans to invest around $100 billion in capital expenditures by 2025.

Source: www.nytimes.com

The impact of Trump’s tariffs on iPhone prices and available affordable alternatives

Amid a tariff frenzy that caused panic among consumers eyeing iPhones, President Trump announced tariff exemptions for electronic devices like smartphones and computers on Friday. This brought relief as there were concerns about the possibility of a $2,000 iPhone.

However, just two days later, the Trump administration hinted that smartphones and computers might face new tariffs targeting semiconductors or chips, potentially leading to a more expensive iPhone. Talk about a rollercoaster!

Despite the uncertainty over iPhone prices due to tariffs, there are still cheaper alternatives available, such as purchasing previous models.

The key lesson here is that to save money in the high-tech world, it’s best to use your devices for as long as possible.

“Buy the best and hold on,” advised Ramit Sethi, a personal finance expert. “Keeping an item for longer reduces the overall cost of ownership.”

The future costs of high-tech hardware remain uncertain. Nintendo recently postponed plans to launch the $450 Nintendo Switch 2 due to tariff uncertainty. Additionally, prices for accessories like phone chargers are increasing on platforms like Amazon.

To navigate future technology purchases effectively, consider holding onto your devices for longer periods to maximize their value.

Replacing your tech frequently can add up in costs. Calculating the true cost of ownership can help you make informed decisions when purchasing new devices.

By holding onto your devices and using them for a longer period, you can significantly reduce the total cost of ownership over time.

This principle applies not just to smartphones but also to computers and tablets. The longer you keep your devices, the more value you can extract from them.

High-tech products are designed to be long-term investments. Many devices today are built to last for several years, yet consumers tend to upgrade frequently, similar to how people buy new cars more often than necessary.

Developing the habit of replacing your device’s battery periodically can help extend its lifespan and save you money in the long run.

As manufacturers improve repairability, replacing components like batteries becomes more accessible and cost-effective.

In times of uncertainty regarding tariffs and rising prices, opting for refurbished or second-hand phones can provide a cost-effective alternative to buying new models.

Even in the face of potential price increases due to tariffs, there are plenty of affordable options available in the market, similar to buying used cars instead of brand new ones.

By exploring refurbished options and older models, you can find cost-effective solutions to high-tech purchases.

Rather than worrying about the hypothetical $2,000 iPhone, focus on more pressing financial matters like building an Emergency Savings Fund.

In challenging economic times, it’s essential to prioritize your financial stability over luxury purchases like the latest smartphones. Focus on what truly matters to secure your financial well-being.

Source: www.nytimes.com

Layoffs at the FDA could lead to higher drug prices and jeopardize food safety

Health Secretary Robert F. Kennedy Jr. announced widespread cuts at federal health agencies, including the Food and Drug Administration, which eliminates overlapping services and paper pushers.

However, interviews with more than a dozen current and former FDA staff featured another photo of the widespread impact of layoffs that ultimately cut the agency’s workforce by 20%. Among them are experts who have navigated the maze of law to determine whether expensive drugs can be sold as low-cost generics. Lab scientists who tested food and drugs for contaminants or fatal bacteria. Veterinary department experts investigating avian flu infections. Researchers who monitored advertisements that were aired for false claims about prescription drugs.

In many areas of the FDA, no employee will support overseas inspectors at risk of processing their pay, submitting retirement or layoff documents, or making the most of their agency’s credit card. Even libraries of institutions that relied on subscriptions to medical journals where researchers and experts were now cancelled have been closed.

FDA’s new commissioner, Dr. Marty McCurry, appeared on Wednesday in a much-anticipated appearance at Maryland headquarters. He gave a speech outlining a wide range of issues in the health care system, including an increase in chronic diseases. Employees were not given a formal opportunity to ask questions.

Approximately 3,500 FDA employees are expected to lose employment under the cuts. A spokesman for Health and Human Services did not answer the question.

When the Trump administration ran its first round with the FDA in February, it thwarted a team of scientists who did the nuanced job of ensuring the safety of surgical robots and devices injecting insulin into diabetic children. Some of the layoffs and cuts described as arbitrary volition by former FDA officials have quickly reversed.

Dr. David Kessler, a former agent committee member on the pandemic response under President Biden and White House adviser, said the latest round of layoffs has been deprived of decades of important experience and knowledge from the institution.

“I think it’s devastating, coincidence, thoughtful and confused,” he said. “I think they need to be revoked.”

It remains uncertain whether any of the lost jobs will be restored by the regime. In the interview, 15 current and former staff members spoke on condition of anonymity, some of whom spoke and explained the expected layoffs and expected impacts on food, drugs and medical supplies, fearing unemployment or retaliation.

Source: www.nytimes.com

New car prices feel the pressure as car rates increase.

Customs duties on imported vehicles went into effect on Wednesday. The policy, said to promote investment and employment in the United States by President Trump, is expected to increase new car prices by thousands of dollars according to analysts.

The 25% duty applies to all vehicles assembled outside the United States. As of May 3rd, customs duties will also apply to imported auto parts, adding to the costs of automobiles and auto repairs.

There is a partial exemption for cars manufactured in Mexico or Canada under a free trade agreement. Automakers do not have to pay duties on parts like engines, transmissions, batteries, and other items that were made in the US and installed in cars at factories in Mexico or Canada.

This provision reduces the impact on vehicles such as Chevrolet Equinox electric vehicles assembled in Mexico but containing battery packs and other US-made components. General Motors only pays duties on some of the cars produced overseas.

Meanwhile, parts duties increase the costs of cars manufactured in states like Michigan, Tennessee, and Ohio where most vehicles contain components made overseas, often accounting for more than half the vehicle cost.

For example, around 90% of the value of some Mercedes-Benz cars made in Alabama comes from engines and transmissions imported from Europe, as per data from the National Highway Traffic Safety Administration.

The impact of tariffs on individual vehicles varies widely. Cars like the Tesla Model Y made in Texas and California or Honda Passports made in Alabama have a higher percentage of US-made parts and pay lower duties.

The highest tariffs apply to cars manufactured overseas, such as the Toyota Prius from Japan and Porsche sports cars from Germany.

Even those not purchasing a new car will feel the impact of tariffs as prices go up for parts like tires, brake pads, and oil filters.

Michael Holmes, co-director of Virginia Tire and Auto, a chain of auto repair and maintenance shops, mentioned that he and his suppliers initially plan to absorb most of the cost increase.

Holmes stated, “It’s not sustainable. It’s wishful thinking to expect companies not to pass on these costs.”

Analysts predict that car tariffs could also drive up prices of used cars in the long run. Increased demand for these vehicles may make new cars unaffordable for many buyers. Furthermore, repair costs may rise, leading to potential increases in insurance premiums.

Source: www.nytimes.com

The Impact of Trump on Auto Prices: How Major Auto Brands are Affected

President Trump announced tariffs on automobiles and auto parts on Wednesday, impacting U.S. and overseas automakers.

Each company has different vulnerabilities based on their circumstances.

Tesla, led by Elon Musk, sells cars from its U.S. plants, potentially making it less exposed to tariffs.

However, Tesla sources parts internationally, with about a quarter of the car’s value coming from overseas.

Tesla’s global sales are declining, partially due to Musk’s political activities, making it a target for retaliation against Trump’s tariffs in some countries.

GM, America’s largest automaker, imports many popular vehicles, potentially making it vulnerable to tariffs.

Despite strong profits, GM relies on overseas assembly for around 40% of its U.S. sales, which could be impacted by tariffs.

Ford is less reliant on imports, with most vehicles sold in the U.S. being domestically produced.

However, Ford still depends on foreign factories for key components like engines.

Stellantis, formed by the merger of Fiat Chrysler and Peugeot, is facing sales challenges and CEO transitions, putting it at risk.

Toyota, like other Japanese automakers, sells a significant number of cars in the U.S. but manufactures many vehicles overseas.

Despite the dependence on foreign production, Toyota is considered one of the strongest global automakers.

Volkswagen, with limited U.S. factories, imports many vehicles, potentially impacting its operations.

Volkswagen has faced financial struggles, especially with declining sales in China and the rise of domestic electric vehicles.

Both Korean companies have seen growth in U.S. sales and are investing in local production to avoid tariffs on certain models.

Hyundai and Kia continue to import cars into the U.S., facing potential tariffs despite their investments in local manufacturing.

Source: www.nytimes.com

Tesla sees largest revenue decline since 2012, yet stock prices remain on the rise

After the earnings release, Tesla stock plummeted by 10% in after-hours trading on Tuesday. This was despite missing Q1 2024 sales, having sharply lower profits, and recalling the recently launched $100,000 Cybertruck, which had seen a recent rise.

The electric vehicle maker’s revenue stood at $21.3 billion, slightly below expectations of $21.48 billion and down by 9% from a year ago, marking the largest decline since 2012. Profits were reported at $1.1 billion, a 55% drop from the first quarter of 2023, the company announced.

Despite the disappointing figures, the report also included upbeat news for investors. This included a preview of a ride-hailing app set to be integrated into Tesla products. The company revealed plans to bring new vehicle models to the market sooner than anticipated, citing the development of its robotaxi network.

Over the past three months, Tesla has doubled its AI computing capacity (smart software complexity) and invested $1 billion in AI infrastructure during the same period.


Thomas Monteiro, senior analyst at the company, mentioned that Tuesday’s report and Tesla’s plans to accelerate the development of more affordable vehicles helped alleviate some concerns among investors. “This announcement suggests that Elon [Musk] may refocus on the EV giant, which is positive news for shareholders,” he stated.

The earnings report was Tesla’s second since the launch of the Cybertruck, its long-awaited electric pickup truck. It was also the first report after the vehicle’s recent recall. The company faced challenges with the futuristic steel car, including a voluntary recall due to reports of a loose accelerator pedal potentially causing vehicles to become stuck when driving at full speed. Despite this, the company did not directly address the recall in its earnings release.

Even without the Cybertruck issues, Tesla has a tough year ahead as it announced a 10% reduction in its global workforce, affecting approximately 14,000 jobs. The company also slashed prices globally over the weekend. The entry of Chinese electric car manufacturers into the market has added to Tesla’s struggles in recent quarters.

Tesla reported a decrease in car deliveries for the first time in four years in the last quarter. The company warned that the growth rate in car sales could be considerably lower compared to 2023.

Addressing concerns about his workload, Elon Musk stated during the earnings conference, “Tesla consumes the majority of my work time. I work every day. I will ensure that Tesla prospers.”

Source: www.theguardian.com

Consumer Affairs: Airbnb host raises prices by 39% following reservation

My daughter used my credit card to book a 5-month stay using Airbnb after taking an internship in Toronto. After the host accepted the booking, she received an email saying the entire stay had increased by £4,000 for her (plus 39% for her).

In a panic, she canceled because she couldn’t afford to pay the extra fee. Airbnb took it. There is a £1,962 handling fee plus £682 cleaning fee and tax. Her daughter canceled immediately, so it is unlikely that your reservation will be lost.

Airbnb endlessly cites its terms of service. I asked the host to give me the money back, but he said he wouldn’t give it back. Feels as if it helped this guy perpetuate something. Seems like a scam.

JS,

on mail

I’m surprised Airbnb didn’t resolve this issue in your favor before I got involved. You were asked to pay an additional 39% after booking – seriously? Fortunately, the company has now refunded you the full amount.

I was told that I should have declined the host’s request for additional fees. In that case, it was up to the host to decide whether to proceed at the original rate or cancel.

You wonder who at the company came up with the terms and conditions that allow for such a request, but all’s well that ends well. I hope your daughter enjoys Toronto.

We welcome letters, but cannot respond individually. Email us at Consumer.champions@theguardian.com or write to Consumer Champions, Money, the Guardian, 90 York Way, London N1 9GU. Please enter a phone number where you can be reached during the day. Submission and publication of all letters is subject to our Terms of Use.

Source: www.theguardian.com

The impact of climate change on food costs: A prediction of rising prices and worsening conditions

Food prices are on the rise

AFP (via Getty Images)

Because of global warming, you are already paying more and more for groceries. And rising temperatures will cause food prices to rise significantly over the next decade.

By 2035, rising temperatures alone are expected to increase global food prices by 0.9 to 3.2 percent each year, according to a study conducted in collaboration with the European Central Bank. This would increase the overall inflation rate by 0.3 to 1.2 percentage points.

“We are often shocked and surprised by the magnitude of these effects,” he says. Maximilian Kotz He mentioned discussions he had with economists during his research at Germany's Potsdam Institute for Climate Impact Research.

Abnormal weather due to global warming Increasingly impacting food production around the world And if farmers don't adapt, the losses will become even more severe as the world continues to warm.

To find out how this is affecting food prices, Kotz and his colleagues looked at monthly price data for a variety of goods and services for 121 countries from 1996 to 2021 and the exposure to which those countries were exposed. The weather conditions were compared.

Researchers looked at the correlation between food prices and factors such as average monthly temperatures, temperature fluctuations, droughts and extreme rainfall. They found a strong association between average temperature and food prices a month or so later.

Areas north of 40 degrees latitude, such as New York City, Madrid, and Beijing, experienced warmer-than-average winter temperatures, leading to lower food prices. But not just in the summer, temperatures in other parts of the world have always been above average, causing food prices to rise.

Moreover, the impact on prices is long-lasting. “If prices go up based on one of these shocks, they stay high for at least the rest of the period,” Kotz says.

The study didn't look at why prices have increased, but one possible explanation is that extreme heat is reducing yields, he said. “The vines may be dry when the crop should be harvested.”

Kotz said factors such as extreme rainfall had a smaller impact on food prices than average temperatures. This may be because flooding tends to be localized, whereas above-average temperatures can be very widespread.

Other studies have reached similar conclusions, Kotz said. But his team went a step further and investigated how food prices would change based on increases in average temperatures in climate model projections. Under the team's worst-case emissions scenario, global food inflation due to climate change will exceed 4% per year by 2060. However, the team believes the 2035 prediction is more reliable, as many other factors could have changed by then.

“There are a lot of things that could happen that will change the way the economy responds to climate change,” Kotz said. For example, inflationary pressures would be reduced if farmers adapted their practices to better cope with rising temperatures. But so far, he says, there is no sign that farmers are adapting.

“I think these are realistic predictions. They are based on solid empirical evidence.” Matin Kaim At the University of Bonn, Germany. “We need to recognize the fact that climate change poses new and major challenges to food and nutrition security.”

according to Food Price Index of the Food and Agriculture Organization of the United Nations, The cost of food fell in real terms between 1960 and 2000, but has risen since then. Russia’s invasion of Ukraine in 2022 caused a massive surge – factors that influence this Protests are occurring in many countries. The index price has since fallen, but remains higher than before the invasion.

Like the US Federal Reserve and the Bank of England, the European Central Bank aims to: keep inflation around 2%. Rising food inflation will make achieving this goal even more difficult, Kotz said.

topic:

Source: www.newscientist.com

Margo Price’s Cultural Highlights: A Spotlight on Me

Ccountry singer songwriter margo price Born in Illinois in 1983, she studied dance and theater at Northern Illinois University. She was a fixture in the Nashville music scene for years, waiting in line and working odd jobs while playing in various bands, before releasing her debut album. Midwestern Farmer’s Daughter, in 2016. In 2018 she was nominated for a Grammy Award for Best New Artist and in 2022 she published her memoir. maybe it will be successful. her fourth album, Straysreleased last year, she Tour the UK and Ireland From January 26th (Gorilla, Manchester) to January 30th (Coco, London).

1. movie

Murderer of the Flower Moon (Martin Scorsese, 2023)

Leonardo DiCaprio and Lily Gladstone in Killers of the Flower Moon. Photo: Landmark Media/Alamy

I recently read a book by David Grann. This is one of the saddest true stories I’ve ever read and one that more people should know about. Martin Scorsese’s movies were great. This is a story about the Osage His Nation, a Native American tribe who lived in Oklahoma in the 1920s and became the richest people in the United States, attracting some pretty evil people. Lily Gladstone played the lead role and her performance was breathtaking. Fun fact: They asked me to audition for the role of Robert De Niro’s wife. Of course I didn’t understand it, but it was fun to be a part of it.

2. hobby

of dulcimer

“Easier than lugging your guitar around at the airport”: the traditional Appalachian mountain dulcimer. Photo: Picture Partners/Alamy

I started playing the dulcimer about a year ago and it’s really fun. She started looking for information online, figured out the chords, took one lesson, and then decided to boldly take it on tour and perform in front of people. There are only three strings, so it is very easy to pick up the melody. Now you know why Joni Mitchell travels with her guitar. It’s small and light, so it’s easier than lugging your guitar around at the airport. I hope this will be an opportunity for people over 40 to pick up a new musical instrument.

3. podcast

10% happier

Host Dan Harris was a former news anchor who left the media after suffering panic attacks and battling drug addiction. Although he describes himself as a “fidgety skeptic,” this is a Buddhist-leaning podcast. He has interviewed His Holiness the Dalai Lama, monks, nuns, and guests such as: Esther Perel and La Sarmiento. He’s speaking to people who have gone through some pretty awful things and lived to tell about it, and that gives me perspective. He seems like an honest person and has a dark and dry sense of humor.

Four. biography

Don’t tell anyone the secrets I told you by Lucinda Williams

FBI Probes Falsified Tweets Creating Artificial Rise in Bitcoin Investment Fund Prices

The U.S. Securities and Exchange Commission (SEC) announced Wednesday that it is working with the FBI to investigate fake messages posted to the X social media account.

On Tuesday, hackers posted false news about an incident. A widely anticipated announcement SEC expected to announce on Bitcoin, leading the crypto world soaring prices and wary observers. An SEC spokesperson confirmed to the Guardian in a statement that the fraudulent posts to the @SECGov account were “not initiated or created by the SEC.”

“The SEC continues to investigate this matter and is coordinating with appropriate law enforcement agencies, including the SEC Office of Inspector General and the FBI,” the spokesperson said. The FBI did not immediately respond to a request for additional comment.

X confirmed late Tuesday, following a preliminary investigation, that the SEC's account was compromised when an unidentified person gained control through a third party and via a phone number associated with the account.

An erroneous post on @SECGov said securities regulators had approved holding Bitcoin in exchange-traded funds. The widely anticipated move was expected to bring Bitcoin more mainstream integration and encourage investment – and the initial SEC tweet sent Bitcoin's price soaring nearly $48,000.

The SEC removed the post about 30 minutes after it was posted, and SEC Chairman Gary Gensler said: Confirmed In a post shortly after, it said the agency's account had been compromised and the tweet was “fraudulent.” “The SEC has not approved the listing and trading of spot Bitcoin exchange products,” he said.

But on Wednesday, the S.E.C. Approving 11 Spot Bitcoin Exchange Traded Funds. This approval is a game-changer for Bitcoin, allowing institutional and retail investors to gain exposure to the world's largest cryptocurrency without directly owning Bitcoin, allowing FTX CEO Sam's massive This is a major boost for the cryptocurrency industry, which has been plagued by a series of scandals, including trials and convictions. Money laundering between Bankman Freed and cryptocurrency giant Binance.

“Retail investors seeking exposure to Bitcoin now have easier and more direct access to their assets through many top financial institutions,” said Digital Commerce, a cryptocurrency and blockchain advocacy organization. said Perianne Bowling, founder and CEO of the Chamber. “This alone is a transformational event for hundreds of millions of investors and the Bitcoin community.”

Reuters contributed to this article

Source: www.theguardian.com